Sanofi’s Tzield Approval Adds New Dimension To Endocrinology Story
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery
Some investors have watched their healthcare stock holdings drop in value recently or over the years, yet they…
Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
Diabetes Testing Moves Earlier—and Gets More Complex
By Alyx Arnett For decades, the clinical lab’s contribution to diabetes care followed a familiar script: A patient…
FDA launches multipronged attack on flu vaccines
Key Insights The US Food & Drug Administration refused to review Moderna’s mRNA flu vaccine this week.…
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints NewsRoche unveils data behind BTK inhibitor’s phase 3…
SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the treatment of…
Beyfortus® (nirsevimab) now available in Malaysia to protect all infants against RSV disease
Beyfortus® (nirsevimab) is an available option designed to protect all infants – whether born full-term or pre-term, healthy…
Big Pharma Forces Britain to Take Its Medicine
Global drugmakers including Merck & Co., Eli Lilly & Co. and AstraZeneca Plc are pausing or canceling investments…